17-63477099-G-A

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_000789.4(ACE):​c.5G>A​(p.Gly2Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000611 in 1,309,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G2V) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000026 ( 0 hom. )

Consequence

ACE
NM_000789.4 missense

Scores

3
2
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.967

Publications

5 publications found
Variant links:
Genes affected
ACE (HGNC:2707): (angiotensin I converting enzyme) This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020]
ACE Gene-Disease associations (from GenCC):
  • renal tubular dysgenesis - ACE
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • intracerebral hemorrhage
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.31999275).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000789.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACE
NM_000789.4
MANE Select
c.5G>Ap.Gly2Glu
missense
Exon 1 of 25NP_000780.1P12821-1
ACE
NM_001382700.1
c.-231G>A
5_prime_UTR
Exon 1 of 22NP_001369629.1
ACE
NM_001382701.1
c.-610G>A
5_prime_UTR
Exon 1 of 23NP_001369630.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACE
ENST00000290866.10
TSL:1 MANE Select
c.5G>Ap.Gly2Glu
missense
Exon 1 of 25ENSP00000290866.4P12821-1
ACE
ENST00000953328.1
c.5G>Ap.Gly2Glu
missense
Exon 1 of 25ENSP00000623387.1
ACE
ENST00000884279.1
c.5G>Ap.Gly2Glu
missense
Exon 1 of 25ENSP00000554338.1

Frequencies

GnomAD3 genomes
AF:
0.0000397
AC:
6
AN:
151306
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000395
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
1886
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000259
AC:
3
AN:
1158324
Hom.:
0
Cov.:
28
AF XY:
0.00000178
AC XY:
1
AN XY:
562234
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22734
American (AMR)
AF:
0.000356
AC:
3
AN:
8426
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14802
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25900
South Asian (SAS)
AF:
0.00
AC:
0
AN:
40950
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
26804
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3142
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
968562
Other (OTH)
AF:
0.00
AC:
0
AN:
47004
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000330
AC:
5
AN:
151414
Hom.:
0
Cov.:
31
AF XY:
0.0000270
AC XY:
2
AN XY:
74026
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41336
American (AMR)
AF:
0.000329
AC:
5
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5078
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10432
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67768
Other (OTH)
AF:
0.00
AC:
0
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000453

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Microvascular complications of diabetes, susceptibility to, 3;C3281105:Hemorrhage, intracerebral, susceptibility to;C5681536:Renal tubular dysgenesis of genetic origin (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.010
T
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.23
FATHMM_MKL
Benign
0.58
D
LIST_S2
Benign
0.46
T
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.32
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N
PhyloP100
0.97
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
0.15
N
REVEL
Benign
0.037
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.0090
B
Vest4
0.42
MutPred
0.19
Gain of solvent accessibility (P = 0.0789)
MVP
0.69
MPC
0.12
ClinPred
0.49
T
GERP RS
3.4
PromoterAI
0.41
Neutral
Varity_R
0.14
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs558593002; hg19: chr17-61554460; API